Press/Media
- 575 - 600 out of 792 results
Search results
-
SENATE HEALTH COMMITTEE VOTES TO CONFIRM DR. LANCE FRYE AS COMMISSIONER OF HEALTH
22/03/21
1 item of Media coverage
Press/Media
-
Senate panel advances Stitt's health commissioner nominee
22/03/21
23 items of Media coverage
Press/Media
-
OSU-COM STUDENTS VOLUNTEER WITH TAHLEQUAH HABITAT FOR HUMANITY
19/03/21
1 item of Media coverage
Press/Media
-
State responds to lawsuit seeking to stop privatization of health care
17/03/21
2 items of Media coverage
Press/Media
-
Outlook: 'Fortuitous' timing has state better prepared for COVID-19's likely addiction fallout
14/03/21
1 item of Media coverage
Press/Media
-
Outlook: 'Fortuitous' timing has state better prepared for COVID-19's likely addiction fallout
14/03/21
1 item of Media coverage
Press/Media
-
Year in review: A look back at the arrival of COVID-19 in Oklahoma
5/03/21
1 item of Media coverage
Press/Media
-
Year in review: A look back at the arrival of COVID-19 in Oklahoma
5/03/21
1 item of Media coverage
Press/Media
-
We Want To Pay Some Special Attention To A Couple Osteopathic Medical Students
26/02/21
1 item of Media coverage
Press/Media
-
POST-TRANSPLANT MORTALITY AMONG VETERANS ENROLLED IN THE VA AND MEDICARE
24/02/21
1 item of Media coverage
Press/Media
-
American Society of Nephrology: Post-Transplant Mortality Among Veterans Enrolled in the VA and Medicare
19/02/21
2 items of Media coverage
Press/Media
-
Post-Transplant Mortality among Veterans Enrolled in the VA and Medicare
18/02/21
1 item of Media coverage
Press/Media
-
10 effective keys to avoiding childhood stress in pandemic season
16/02/21
1 item of Media coverage
Press/Media
-
FDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
15/02/21
2 items of Media coverage
Press/Media
-
FDA Approves G1 Therapeutics’ COSELA (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
14/02/21
1 item of Media coverage
Press/Media
-
FDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
12/02/21 → 13/02/21
29 items of Media coverage
Press/Media
-
-
-
-
10 Parenting Strategies to Reduce Your Kids’ Pandemic Stress
8/02/21
1 item of Media coverage
Press/Media
-
-
-
-
Vaccine supply expected to increase in state; Pharmacies to begin vaccination clinics
5/02/21
1 item of Media coverage
Press/Media